These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31605843)

  • 61. Symptomatic Hemorrhage From Cerebral Cavernous Malformations: Evidence from a Cohort Study.
    Gomez-Paz S; Maragkos GA; Salem MM; Ascanio LC; Lee M; Enriquez-Marulanda A; Orrego-Gonzalez E; Kicielinski K; Moore JM; Ogilvy CS; Thomas AJ
    World Neurosurg; 2020 Mar; 135():e477-e487. PubMed ID: 31843731
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical features of cerebral cavernous malformations patients with KRIT1 mutations.
    Denier C; Labauge P; Brunereau L; Cavé-Riant F; Marchelli F; Arnoult M; Cecillon M; Maciazek J; Joutel A; Tournier-Lasserve E; ;
    Ann Neurol; 2004 Feb; 55(2):213-20. PubMed ID: 14755725
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rehemorrhage of brainstem cavernous malformations: a benchmark approach to individualized risk and severity assessment.
    Li Z; Ma L; Quan K; Liu P; Shi Y; Liu Y; Zhu W
    J Neurosurg; 2023 Jul; 139(1):94-105. PubMed ID: 36585870
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pontine cavernoma hemorrhage leading to Millard-Gubler syndrome.
    Kesikburun S; Safaz I; Alaca R
    Am J Phys Med Rehabil; 2011 Mar; 90(3):263. PubMed ID: 20531153
    [No Abstract]   [Full Text] [Related]  

  • 65. Solitary Sporadic Cerebral Cavernous Malformations: Risk Factors of First or Recurrent Symptomatic Hemorrhage and Associated Functional Impairment.
    Dammann P; Jabbarli R; Wittek P; Oppong MD; Kneist A; Zhu Y; Wrede K; Müller O; Forsting M; Sure U
    World Neurosurg; 2016 Jul; 91():73-80. PubMed ID: 27058610
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Radiosurgical, neurosurgical, or no intervention for cerebral cavernous malformations: A decision analysis.
    Rinkel LA; Al-Shahi Salman R; Rinkel GJ; Greving JP
    Int J Stroke; 2019 Dec; 14(9):939-945. PubMed ID: 31122172
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hemorrhage risk, surgical management, and functional outcome of brainstem cavernous malformations.
    Li D; Yang Y; Hao SY; Wang L; Tang J; Xiao XR; Zhou H; Jia GJ; Wu Z; Zhang LW; Zhang JT
    J Neurosurg; 2013 Oct; 119(4):996-1008. PubMed ID: 23952884
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cavernous malformations.
    Smith ER; Scott RM
    Neurosurg Clin N Am; 2010 Jul; 21(3):483-90. PubMed ID: 20561497
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Risk for symptomatic hemorrhage of cerebral cavernous malformations during pregnancy.
    Kalani MY; Zabramski JM
    J Neurosurg; 2013 Jan; 118(1):50-5. PubMed ID: 23039155
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Update on the natural history of cavernous malformations and factors predicting aggressive clinical presentation.
    Washington CW; McCoy KE; Zipfel GJ
    Neurosurg Focus; 2010 Sep; 29(3):E7. PubMed ID: 20809765
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations.
    Girard R; Zeineddine HA; Fam MD; Mayampurath A; Cao Y; Shi C; Shenkar R; Polster SP; Jesselson M; Duggan R; Mikati AG; Christoforidis G; Andrade J; Whitehead KJ; Li DY; Awad IA
    Transl Stroke Res; 2018 Feb; 9(1):34-43. PubMed ID: 28819935
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Incidence, Prevalence, and Clinical Presentation of Cerebral Cavernous Malformations.
    Flemming KD
    Methods Mol Biol; 2020; 2152():27-33. PubMed ID: 32524541
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Surgical Management and Long-Term Seizure Outcome After Surgery for Temporal Lobe Epilepsy Associated with Cerebral Cavernous Malformations.
    Yang PF; Pei JS; Jia YZ; Lin Q; Xiao H; Zhang TT; Zhong ZH
    World Neurosurg; 2018 Feb; 110():e659-e670. PubMed ID: 29175574
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hypertrophic olivary degeneration following pontine cavernoma hemorrhage: a typical change accompanying lesions in the Guillain-Mollaret triangle.
    Macht S; Hänggi D; Turowski B
    Klin Neuroradiol; 2009 Aug; 19(3):235-7. PubMed ID: 19727585
    [No Abstract]   [Full Text] [Related]  

  • 75. Natural History of Brainstem Cavernous Malformations: On the Variation in Hemorrhage Rates.
    Yang Y; Velz J; Neidert MC; Stienen MN; Regli L; Bozinov O
    World Neurosurg; 2022 Jan; 157():e342-e350. PubMed ID: 34656794
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Surgical Treatment of Cerebellar Cavernous Malformations: A Single-Center Experience with 58 Cases.
    Wu H; Yu T; Wang S; Zhao J; Zhao Y
    World Neurosurg; 2015 Oct; 84(4):1103-11. PubMed ID: 26070634
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Subclinical imaging changes in cerebral cavernous angiomas during prospective surveillance.
    Carrión-Penagos J; Zeineddine HA; Polster SP; Girard R; Lyne SB; Koskimäki J; Romanos S; Srinath A; Zhang D; Cao Y; Stadnik A; Piedad K; Shenkar R; Awad IA
    J Neurosurg; 2021 Mar; 134(3):1147-1154. PubMed ID: 32244216
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ruptured pontine cavernomas in infants: a report of two cases.
    Florian IA; Timis TL; Kiss KR; Florian IS; Berindan-Neagoe I
    Childs Nerv Syst; 2021 Mar; 37(3):1009-1015. PubMed ID: 33070216
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The natural history of cerebral cavernous malformations.
    Kondziolka D; Lunsford LD; Kestle JR
    J Neurosurg; 1995 Nov; 83(5):820-4. PubMed ID: 7472549
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Association Between Beta-Blocker or Statin Drug Use and the Risk of Hemorrhage From Cerebral Cavernous Malformations.
    Zuurbier SM; Hickman CR; Rinkel LA; Berg R; Sure U; Al-Shahi Salman R;
    Stroke; 2022 Aug; 53(8):2521-2527. PubMed ID: 35410492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.